AAPL327.47+5.81 (+1.81%) ▲|ABBV259.24+2.32 (+0.90%) ▲|ABT102.42+1.67 (+1.66%) ▲|ACN144.04+5.30 (+3.82%) ▲|ADBE219.40+7.23 (+3.41%) ▲|AMAT547.41-15.40 (-2.74%) ▼|AMD524.18-15.51 (-2.87%) ▼|AMGN376.75+5.25 (+1.41%) ▲|AMT169.27+4.62 (+2.80%) ▲|AMZN232.83-0.84 (-0.36%) ▼|AVGO382.28-10.19 (-2.60%) ▼|AXP321.64-19.21 (-5.63%) ▼|BA209.29+0.06 (+0.03%) ▲|BAC61.83+0.55 (+0.90%) ▲|BKNG175.37+2.54 (+1.47%) ▲|BLK1,040.77+3.61 (+0.35%) ▲|BMY62.21+0.70 (+1.14%) ▲|BNY159.46-0.66 (-0.41%) ▼|BRK-B492.57+1.72 (+0.35%) ▲|C132.69+0.81 (+0.61%) ▲|CAT896.48+1.94 (+0.22%) ▲|CL90.86+0.78 (+0.86%) ▲|CMCSA22.28+0.36 (+1.64%) ▲|COF200.25+0.29 (+0.14%) ▲|COP120.68+0.48 (+0.40%) ▲|COST929.68+3.62 (+0.39%) ▲|CRM161.23+4.30 (+2.74%) ▲|CSCO112.76-0.01 (0.00%) ▼|CVS107.83+0.94 (+0.88%) ▲|CVX194.68+0.26 (+0.13%) ▲|DE613.86+3.84 (+0.63%) ▲|DHR192.21-0.29 (-0.15%) ▼|DIS94.57+1.74 (+1.87%) ▲|DUK130.10+0.84 (+0.65%) ▲|EMR147.10+2.20 (+1.52%) ▲|FDX316.56+0.94 (+0.30%) ▲|GD386.17+4.38 (+1.15%) ▲|GE356.21+7.21 (+2.06%) ▲|GEV1,020.28-10.91 (-1.06%) ▼|GILD129.86-1.01 (-0.77%) ▼|GM82.69+2.02 (+2.50%) ▲|GOOG322.10+3.76 (+1.18%) ▲|GOOGL322.24+4.55 (+1.43%) ▲|GS1,069.88-4.84 (-0.45%) ▼|HD325.84+1.13 (+0.35%) ▲|HON243.71-2.56 (-1.04%) ▼|IBM211.32+4.67 (+2.26%) ▲|INTC96.19-4.04 (-4.03%) ▼|INTU290.04+8.51 (+3.02%) ▲|ISRG335.65+3.63 (+1.09%) ▲|JNJ261.61+2.34 (+0.90%) ▲|JPM350.56+0.66 (+0.19%) ▲|KO81.40+0.23 (+0.28%) ▲|LIN509.87+3.55 (+0.70%) ▲|LLY1,197.81+11.94 (+1.01%) ▲|LMT580.77+12.18 (+2.14%) ▲|LOW204.11+2.19 (+1.08%) ▲|LRCX311.77-8.01 (-2.50%) ▼|MA534.88+4.59 (+0.87%) ▲|MCD264.06+1.26 (+0.48%) ▲|MDLZ59.99-0.06 (-0.10%) ▼|MDT82.78+0.77 (+0.94%) ▲|META604.36-1.74 (-0.29%) ▼|MMM170.75+1.16 (+0.68%) ▲|MO72.73+0.65 (+0.90%) ▲|MRK130.24-0.24 (-0.18%) ▼|MS214.04-1.14 (-0.53%) ▼|MSFT381.95+0.37 (+0.10%) ▲|MU929.06-61.16 (-6.18%) ▼|NEE88.94-0.85 (-0.95%) ▼|NFLX69.20+0.31 (+0.45%) ▲|NKE41.00+0.01 (+0.02%) ▲|NOW95.93+3.99 (+4.34%) ▲|NVDA207.41-1.35 (-0.65%) ▼|ORCL117.31-2.73 (-2.27%) ▼|PEP134.99+0.04 (+0.03%) ▲|PFE24.55-0.04 (-0.14%) ▼|PG147.08+1.20 (+0.82%) ▲|PLTR122.85-0.52 (-0.42%) ▼|PM193.77+2.65 (+1.39%) ▲|QCOM167.40-3.71 (-2.17%) ▼|RTX211.72+2.56 (+1.22%) ▲|SBUX104.47+1.26 (+1.22%) ▲|SCHW101.77+0.16 (+0.15%) ▲|SO97.50+0.90 (+0.93%) ▲|SPG227.65+2.45 (+1.09%) ▲|T23.61+0.65 (+2.83%) ▲|TMO562.62-9.70 (-1.69%) ▼|TMUS177.36+6.94 (+4.07%) ▲|TSLA315.64-4.05 (-1.27%) ▼|TXN279.89-5.10 (-1.79%) ▼|UBER68.75-0.17 (-0.24%) ▼|UNH423.17-0.39 (-0.09%) ▼|UNP303.11-1.22 (-0.40%) ▼|UPS114.05-0.05 (-0.04%) ▼|USB63.65+0.32 (+0.51%) ▲|V353.23+1.63 (+0.46%) ▲|VZ45.06+1.24 (+2.82%) ▲|WFC86.24+0.05 (+0.06%) ▲|WMT108.88+0.48 (+0.44%) ▲|XOM157.22+0.33 (+0.21%) ▲|AAPL327.47+5.81 (+1.81%) ▲|ABBV259.24+2.32 (+0.90%) ▲|ABT102.42+1.67 (+1.66%) ▲|ACN144.04+5.30 (+3.82%) ▲|ADBE219.40+7.23 (+3.41%) ▲|AMAT547.41-15.40 (-2.74%) ▼|AMD524.18-15.51 (-2.87%) ▼|AMGN376.75+5.25 (+1.41%) ▲|AMT169.27+4.62 (+2.80%) ▲|AMZN232.83-0.84 (-0.36%) ▼|AVGO382.28-10.19 (-2.60%) ▼|AXP321.64-19.21 (-5.63%) ▼|BA209.29+0.06 (+0.03%) ▲|BAC61.83+0.55 (+0.90%) ▲|BKNG175.37+2.54 (+1.47%) ▲|BLK1,040.77+3.61 (+0.35%) ▲|BMY62.21+0.70 (+1.14%) ▲|BNY159.46-0.66 (-0.41%) ▼|BRK-B492.57+1.72 (+0.35%) ▲|C132.69+0.81 (+0.61%) ▲|CAT896.48+1.94 (+0.22%) ▲|CL90.86+0.78 (+0.86%) ▲|CMCSA22.28+0.36 (+1.64%) ▲|COF200.25+0.29 (+0.14%) ▲|COP120.68+0.48 (+0.40%) ▲|COST929.68+3.62 (+0.39%) ▲|CRM161.23+4.30 (+2.74%) ▲|CSCO112.76-0.01 (0.00%) ▼|CVS107.83+0.94 (+0.88%) ▲|CVX194.68+0.26 (+0.13%) ▲|DE613.86+3.84 (+0.63%) ▲|DHR192.21-0.29 (-0.15%) ▼|DIS94.57+1.74 (+1.87%) ▲|DUK130.10+0.84 (+0.65%) ▲|EMR147.10+2.20 (+1.52%) ▲|FDX316.56+0.94 (+0.30%) ▲|GD386.17+4.38 (+1.15%) ▲|GE356.21+7.21 (+2.06%) ▲|GEV1,020.28-10.91 (-1.06%) ▼|GILD129.86-1.01 (-0.77%) ▼|GM82.69+2.02 (+2.50%) ▲|GOOG322.10+3.76 (+1.18%) ▲|GOOGL322.24+4.55 (+1.43%) ▲|GS1,069.88-4.84 (-0.45%) ▼|HD325.84+1.13 (+0.35%) ▲|HON243.71-2.56 (-1.04%) ▼|IBM211.32+4.67 (+2.26%) ▲|INTC96.19-4.04 (-4.03%) ▼|INTU290.04+8.51 (+3.02%) ▲|ISRG335.65+3.63 (+1.09%) ▲|JNJ261.61+2.34 (+0.90%) ▲|JPM350.56+0.66 (+0.19%) ▲|KO81.40+0.23 (+0.28%) ▲|LIN509.87+3.55 (+0.70%) ▲|LLY1,197.81+11.94 (+1.01%) ▲|LMT580.77+12.18 (+2.14%) ▲|LOW204.11+2.19 (+1.08%) ▲|LRCX311.77-8.01 (-2.50%) ▼|MA534.88+4.59 (+0.87%) ▲|MCD264.06+1.26 (+0.48%) ▲|MDLZ59.99-0.06 (-0.10%) ▼|MDT82.78+0.77 (+0.94%) ▲|META604.36-1.74 (-0.29%) ▼|MMM170.75+1.16 (+0.68%) ▲|MO72.73+0.65 (+0.90%) ▲|MRK130.24-0.24 (-0.18%) ▼|MS214.04-1.14 (-0.53%) ▼|MSFT381.95+0.37 (+0.10%) ▲|MU929.06-61.16 (-6.18%) ▼|NEE88.94-0.85 (-0.95%) ▼|NFLX69.20+0.31 (+0.45%) ▲|NKE41.00+0.01 (+0.02%) ▲|NOW95.93+3.99 (+4.34%) ▲|NVDA207.41-1.35 (-0.65%) ▼|ORCL117.31-2.73 (-2.27%) ▼|PEP134.99+0.04 (+0.03%) ▲|PFE24.55-0.04 (-0.14%) ▼|PG147.08+1.20 (+0.82%) ▲|PLTR122.85-0.52 (-0.42%) ▼|PM193.77+2.65 (+1.39%) ▲|QCOM167.40-3.71 (-2.17%) ▼|RTX211.72+2.56 (+1.22%) ▲|SBUX104.47+1.26 (+1.22%) ▲|SCHW101.77+0.16 (+0.15%) ▲|SO97.50+0.90 (+0.93%) ▲|SPG227.65+2.45 (+1.09%) ▲|T23.61+0.65 (+2.83%) ▲|TMO562.62-9.70 (-1.69%) ▼|TMUS177.36+6.94 (+4.07%) ▲|TSLA315.64-4.05 (-1.27%) ▼|TXN279.89-5.10 (-1.79%) ▼|UBER68.75-0.17 (-0.24%) ▼|UNH423.17-0.39 (-0.09%) ▼|UNP303.11-1.22 (-0.40%) ▼|UPS114.05-0.05 (-0.04%) ▼|USB63.65+0.32 (+0.51%) ▲|V353.23+1.63 (+0.46%) ▲|VZ45.06+1.24 (+2.82%) ▲|WFC86.24+0.05 (+0.06%) ▲|WMT108.88+0.48 (+0.44%) ▲|XOM157.22+0.33 (+0.21%) ▲|
25.9 C
New York
Friday, July 24, 2026

Tag: ocular surface

newssourceFORcompanyinformationcontent1releasesmarket

Stem Cell Therapy Market worth $3.65 billion by 2035 | MarketsandMarkets™

DELRAY BEACH, Fla., June 15, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Stem Cell Therapy Market is projected to grow from about USD 0.48 billion...

Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye

Agreement with Selagine, Inc. supports the development of an investigational pooled plasma biologic platform intended to move beyond individualized compounded serum tearsCHICAGO, June 9,...

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 3, 2025 /PRNewswire/ -- Raytone Biotech, a clinical-stage biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient...

Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease

BEIJING, Aug. 4, 2025 /PRNewswire/ -- Raytone Biotech, a biotechnology company dedicated to innovative ophthalmic therapies, announced that it successfully completed the first patient dosing...

Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing...

Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing...

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOcular surface

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers